Here, we report on the identification of the small molecule Acriflavine as a potent inhibitor of the MCT4 – Basigin interaction, cancer stem-like fraction, and cell growth in vitro, and tumor growth in vivo. This evidence concerns the gene SLC16A3 and cancer.